Prof. Dr. med. Sven Mahner - LION Studie - Rolle der Lymphknotenentfernung bei Erstoperation des Eierstockkrebs from Oncoletter on Vimeo.
LION (Phase III Trial): Lymphadenectomy for LN-Negative Advanced Ovarian Cancer Following Complete Resection
According to the autors In the phase III LION trial, systemic pelvic and para-aortic lymphadenectomy offered no survival benefit and increased postoperative morbidity and mortality in patients with advanced ovarian cancer, macroscopic complete resection, and clinically/radiographically negative lymph nodes.